未登录.png)
分享.png)
收藏分享 收藏 Interdental Brushing and Obstetrical Outcomes in Nulliparous Pregnant Women: Insights From a Cluster Randomised Controlled Trial邻间刷牙与非孕产妇结局的关系：一项集群随机对照试验的启示
Bourgeois, Denis; Kanoute, Aida; Faye, Daouda; Mazur, Marta; Perrier, Herve; Ardan, Roman; Clement, Celine; Goncalves, Lucio Souza; Lan, Romain; Carrouel, Florence 分享 收藏 Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohortTougeron, David; Bibeau, Frederic; Chibaudel, Benoist; Kim, Stefano; Nguyen, Thierry; Phelip, Jean-Marc; Mille, Dominique; Bouattour, Mohamed; Tavani, David; Rinaldij, Yves; Lecomte, Thierry; Perrier, Herve; Spaeth, Dominique; Bosc, Francois-Xavier Caroli; Metges, Jean-Philippe; Ferec, Marc; Hautefeuille, Vincent; Deslandres-Cruchant, Marion; Danion, Jerome; Hammel, Pascal; Lewin, Matie; Tasu, Jean-Pierre; Angelergues, Antoine; Difiore, Frederic; Evrard, Serge; Mansar, Racha; Caillou, Hugo; Geffriaud-Ricouard, Christine; Adam, Rene 分享 收藏 Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial基于瘦体重的奥沙利铂剂量对III期结直肠癌辅助治疗中神经毒性的影响：LEANOX多中心随机II期试验的最终结果Assenat, E.; Ben Abdelghani, M.; Gourgou, S.; Perrier, H.; Akouz, F. Khemissa; Desgrippes, R.; Galais, M. P.; Janiszewski, C.; Rinaldi, Y.; Lepage, C.; Tetreau, R.; Senesse, P. 分享 收藏 Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial帕博利珠单抗联合CAPOX和贝伐珠单抗治疗微卫星稳定型转移性结直肠癌且免疫浸润水平高的患者：FFCD 1703 POCHI试验的初步结果Tougeron, D.; Emile, J-F.; Bodere, A.; Barbier, E.; Bez, J.; Dourthe, L. M.; Perrier, H.; Corbinais, S.; Le Brun-Ly, V.; Bideau, K.; Chibaudel, B.; Akouz, F. Khemissa; Hartwig, J.; Laly, M.; Lievre, A.; Toullec, C.; Lomenie, N.; Laurent-Puig, P.; Lepage, C.; Taieb, J. 分享 收藏 Trifluridine/tipiracil plus oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trialBotsen, Damien; Chabaud, Sylvie; Perrier, Herve; Ammarguellat, Hanifa; Jestin-Le-Tallec, Veronique; Olesinski, Jonathan; Toullec, Clemence; Aparicio, Thomas; Ben Abdelghani, Meher; Borg, Christophe; Bouche, Olivier; Coutzac, Clelia; Devaud, Herve; Di Fiore, Frederic; Dubreuil, Olivier; Evesque, Ludovic; Huguenin, Bruno; Muller, Marie; Poureau, Pierre-Guillaume; Oularue, Emilie; Tougeron, David; Zaanan, Aziz; Ammari, Samy; Carvalho, Nicolas De Sousa; Decazes, Pierre; De La Fouchardiere, Christelle 分享 收藏 Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trialTougeron, D.; Emile, J. F.; Bodere, A.; Barbier, E.; Bez, J.; Dourthe, L. M.; Perrier, H.; Corbinais, S.; Le Brun-Ly, V.; Bideau, K.; Chibaudel, B.; Khemissa, F.; Hartwig, J.; Laly, M.; Lievre, A.; Toullec, C.; Muller, M.; Laurent-Puig, P.; Lepage, C.; Taieb, J. 分享 收藏 Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimensdu Rusquec, P.; Guimbaud, R.; Le Malicot, K.; Gornet, J. -m.; Nguyen, S.; Lecomte, T.; Khemissa-Akouz, F.; Perrier, H.; Bouche, O.; Paoletti, X.; Le Tourneau, C. 分享 收藏 Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and PrognosisAdhoute, Xavier; Pietri, Olivia; Penaranda, Guillaume; Wolf, Thomas; Beaurain, Patrick; Monnet, Olivier; Laquiere, Arthur; Bonomini, Justine; Neumann, Frederic; Levrel, Olivier; Buono, Jean-Pascal; Hanna, Xavier; Castellani, Paul; Perrier, Herve; Bourliere, Marc; Anty, Rodolphe 分享 收藏 分享 收藏 Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trialCarrouel, Florence; Valette, Martine; Gadea, Emilie; Esparcieux, Aurelie; Illes, Gabriela; Langlois, Marie Elodie; Perrier, Herve; Dussart, Claude; Tramini, Paul; Ribaud, Melina; Bouscambert-Duchamp, Maude; Bourgeois, Denis 分享 收藏 分享 收藏 Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trialTaieb, Julien; Andre, Thierry; El Hajbi, Farid; Barbier, Emilie; Toullec, Clemence; Kim, Stefano; Bouche, Olivier; Di Fiore, Frederic; Chauvenet, Marion; Perrier, Herve; Evesque, Ludovic; Laurent-Puig, Pierre; Emile, Jean-Francois; Bez, Jeremie; Lepage, Come; Tougeron, David 分享 收藏 Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trialPhelip, J. M.; Desrame, J.; Edeline, J.; Barbier, E.; Terrebonne, E.; Michel, P.; Perrier, H.; Dahan, L.; Bourgeois, V.; Akouz, F. Khemissa; Soularue, E.; Lebrun, V. Ly; Molin, Y.; Lecomte, T.; Ghiringhelli, F.; Coriat, R.; Louafi, S.; Neuzillet, C.; Manfredi, S.; Malka, D. 分享 收藏 PRODIGE 65-UCGI 36-GEMPAX : A unicancer phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinomade la Fouchardiere, C.; Hammel, P.; Launay, S.; Vienot, A.; Raimbourg, J.; Perrier, H.; Evesque, L.; Ghiringhelli, F.; Jary, M.; Aparicio, T.; Hocine, F.; Neuzillet, C.; Botsen, D.; Phelip, J. M.; Peytier, A.; Michel, P.; Cropet, C.; Lachaux, N.; Chabaud, S.; Dahan, L. 分享 收藏 Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patientsAparicio, Thomas; Henriques, Julie; Manfredi, Sylvain; Tougeron, David; Bouche, Olivier; Pezet, Denis; Piessen, Guillaume; Coriat, Romain; Zaanan, Aziz; Legoux, Jean-Louis; Terrebone, Eric; Pocard, Marc; Gornet, Jean-Marc; Lecomte, Thierry; Lombard-Bohas, Catherine; Perrier, Herve; Lecaille, Cedric; Lavau-Denes, Sandrine; Vernerey, Dewi; Afchain, Pauline 分享 收藏 FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trialFOLFOX单独或联合rilotumumab或panitumumab作为晚期胃食管腺癌患者的一线治疗 (PRODIGE 17-ACCORD 20-MEGA): 一项随机，开放标签，三臂II期试验Malka, David; Francois, Eric; Penault-Llorca, Frederique; Castan, Florence; Bouche, Olivier; Bennouna, Jaafar; Ghiringhelli, Francois; de la Fouchardiere, Christelle; Borg, Christophe; Samalin, Emmanuelle; Bachet, Jean-Baptiste; Raoul, Jean-Luc; Miglianico, Laurent; Bengrine-Lefevre, Leila; Dahan, Laetitia; Lecaille, Cedric; Aparicio, Thomas; Stanbury, Trevor; Perrier, Herve; Cayre, Anne; Laurent-Puig, Pierre; Gourgou, Sophie; Emile, Jean-Francois; Taieb, Julien 分享 收藏 分享 收藏 Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortAdhoute, Xavier; Penaranda, Guillaume; Raoul, Jean Luc; Edeline, Julien; Blanc, Jean-Frederic; Pol, Bernard; Campanile, Manuela; Perrier, Herve; Bayle, Olivier; Monnet, Olivier; Beaurain, Patrick; Muller, Cyril; Castellani, Paul; Le Treut, Yves Patrice; Bronowicki, Jean Pierre; Bourliere, Marc 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
OAAI.png){kind=icon}